NASDAQ:COSM Cosmos Health (COSM) Stock Price, News & Analysis $0.25 0.00 (0.00%) Closing price 05/22/2026 04:00 PM EasternExtended Trading$0.26 +0.00 (+0.99%) As of 05/22/2026 07:19 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Cosmos Health Stock (NASDAQ:COSM) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Cosmos Health alerts:Sign Up Key Stats Today's Range$0.25▼$0.2750-Day Range$0.25▼$0.4152-Week Range$0.25▼$1.32Volume402,932 shsAverage Volume872,757 shsMarket Capitalization$13.74 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingSell Company Overview Cosmos Health Inc. manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names. The company serves wholesale distributors and other healthcare providers, such as clinics, government agencies, independent retail and specialty pharmacies and independent specialty distributors. It sells its products through independent wholesale distributors. Cosmos Health Inc. was incorporated in 2009 and is headquartered in Chicago, Illinois. Read More Cosmos Health Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks10th Percentile Overall ScoreCOSM MarketRank™: Cosmos Health scored higher than 10% of companies evaluated by MarketBeat, and ranked 825th out of 867 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion0.5 / 5Analyst RatingSell Consensus RatingCosmos Health has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.Amount of Analyst CoverageCosmos Health has received no research coverage in the past 90 days.Read more about Cosmos Health's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings Growth-12.50% Earnings GrowthEarnings for Cosmos Health are expected to decrease by -12.50% in the coming year, from $0.08 to $0.07 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Cosmos Health is -0.39, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Cosmos Health is -0.39, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioCosmos Health has a P/B Ratio of 0.70. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted1.59% of the float of Cosmos Health has been sold short.Short Interest Ratio / Days to CoverCosmos Health has a short interest ratio ("days to cover") of 0.39, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Cosmos Health has recently increased by 21.98%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldCosmos Health does not currently pay a dividend.Dividend GrowthCosmos Health does not have a long track record of dividend growth. News and Social Media1.6 / 5News Sentiment-0.36 News SentimentCosmos Health has a news sentiment score of -0.36. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.47 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 4 news articles for Cosmos Health this week, compared to 4 articles on an average week.Search InterestOnly 1 people have searched for COSM on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.MarketBeat Follows7 people have added Cosmos Health to their MarketBeat watchlist in the last 30 days. This is an increase of 600% compared to the previous 30 days. Company Ownership0.9 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Cosmos Health insiders have not sold or bought any company stock.Percentage Held by Insiders25.10% of the stock of Cosmos Health is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions12.61% of the stock of Cosmos Health is held by institutions.Read more about Cosmos Health's insider trading history. Receive COSM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cosmos Health and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. COSM Stock News HeadlinesCosmos Health Inc.: Cosmos Health Announces Expiration of 4,874,126 Series B Warrants Unexercised; ~38% of Total Outstanding WarrantsMay 22, 2026 | finanznachrichten.deCosmos Health Reports Q1 2026 Results: Revenue Up 31% to $17.9M, New Q1 Record; Total Liabilities Reduced by $4.5M; Stockholders' Equity Up 7.6%; Cash of $2.2M; Record Momentum ...May 22, 2026 | finance.yahoo.comHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall of Fame Trader Jon Najarian now says EVERYONE is missing an even bigger story about the SpaceX IPO… That it's just the start of an Elon Musk $44 trillion "Superconvergence…" An event that could kick off as soon as June 12th.May 26 at 1:00 AM | Banyan Hill Publishing (Ad)COSM shows rapid revenue riseMay 22, 2026 | msn.comCosmos Health Inc.: Cosmos Health Announces Withdrawal of Registration Statement on Form S-1May 12, 2026 | finanznachrichten.deCosmos Health Inc COSMMay 9, 2026 | morningstar.comMCosmos Health Inc.: Cosmos Health Receives Updated Zacks Research Report: 2026 Revenue Forecast Raised to $103.2 Million, EPS Outlook Upgraded to Positive Territory, and $4.50 ...May 8, 2026 | finanznachrichten.deCosmos Health Inc: Cosmos Health Introduces Fort18 in the United States - A Men's Sexual Stamina Supplement Expanding the 18 Series into Men's WellnessMay 7, 2026 | finanznachrichten.deSee More Headlines COSM Stock Analysis - Frequently Asked Questions How have COSM shares performed this year? Cosmos Health's stock was trading at $0.4980 at the beginning of the year. Since then, COSM stock has decreased by 49.3% and is now trading at $0.2525. How were Cosmos Health's earnings last quarter? Cosmos Health Inc. (NASDAQ:COSM) announced its quarterly earnings results on Thursday, May, 21st. The company reported ($0.06) earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of ($0.06). The firm had revenue of $18.40 million for the quarter, compared to analyst estimates of $17.93 million. Cosmos Health had a negative net margin of 30.41% and a negative trailing twelve-month return on equity of 52.85%. When did Cosmos Health's stock split? Cosmos Health's stock reverse split before market open on Thursday, December 15th 2022.The 1-25 reverse split was announced on Thursday, December 15th 2022. The number of shares owned by shareholders was adjusted after the market closes on Thursday, December 15th 2022. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split. Who are Cosmos Health's major shareholders? Top institutional shareholders of Cosmos Health include Renaissance Technologies LLC (0.75%). Insiders that own company stock include Grigorios Siokas and Georgios Terzis. View institutional ownership trends. How do I buy shares of Cosmos Health? Shares of COSM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Cosmos Health own? Based on aggregate information from My MarketBeat watchlists, some other companies that Cosmos Health investors own include Meta Platforms (META), NVIDIA (NVDA), Adobe (ADBE), Broadcom (AVGO), CrowdStrike (CRWD), Arista Networks (ANET) and Builders FirstSource (BLDR). Company Calendar Last Earnings5/21/2026Today5/26/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (3m+) 1-Year History May 25 Aug 25 Nov 25 Feb 26 May 26 COSM's financial health is in the Red zone, according to TradeSmith. COSM has been in this zone for over 3 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED - DRUGS Sub-IndustryWholesale Current SymbolNASDAQ:COSM CIK1474167 Webwww.cosmosholdingsinc.com Phone(312) 536-3102FaxN/AEmployees100Year FoundedN/AProfitability EPS (Trailing Twelve Months)($0.64) Trailing P/E RatioN/A Forward P/E Ratio3.16 P/E GrowthN/ANet Income-$19.15 million Net Margins-30.41% Pretax Margin-30.41% Return on Equity-52.85% Return on Assets-17.87% Debt Debt-to-Equity Ratio0.31 Current Ratio1.08 Quick Ratio0.85 Sales & Book Value Annual Sales$65.27 million Price / Sales0.21 Cash FlowN/A Price / Cash FlowN/A Book Value$0.36 per share Price / Book0.70Miscellaneous Outstanding Shares54,430,000Free Float40,767,000Market Cap$13.74 million OptionableOptionable Beta5.00 The 7 Hottest IPOs On Wall Street’s 2026 WatchlistMarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.Get This Free Report This page (NASDAQ:COSM) was last updated on 5/26/2026 by MarketBeat.com Staff. From Our PartnersHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | SponsoredThe SpaceX supplier that shipped 5 billion chips to StarlinkWhen Nvidia surged 770%, its data center cooling supplier Vertiv climbed 1,700%. When Apple ran 2,000%, suppli...Weiss Ratings | SponsoredThree companies about to leapfrog Nvidia [And transform the entire industry]Futurist George Gilder - who predicted the smartphone years before the iPhone launched - believes today's AI d...Eagle Publishing | SponsoredThe S-1 just dropped. 22 days left.The SpaceX S-1 is now public - $18.7 billion in revenue, a $75 billion raise, and a June 12 Nasdaq listing con...Behind the Markets | SponsoredMy crisis of conscienceEmmet Savage - named in Irish America's Wall Street 50 as one of the most successful investors in the world - ...Porter & Company | SponsoredYour book attachedBill Poulos is offering his 'Simple Options Trading For Beginners' guide at no cost - normally priced at $29.9...Profits Run | SponsoredSkip the Line Opportunity: The SpaceX IPOFormer tech executive and angel investor Jeff Brown - who identified Bitcoin, Tesla, and Nvidia before their h...Brownstone Research | SponsoredFINAL HOURS: $9 Income ETF Access VANISHES at MIDNIGHTTim Plaehn's income ETF research is available at 82% off - but only until midnight tonight. This Memorial Day ...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cosmos Health Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cosmos Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
